Late-Breaking Results Show Nipocalimab Significantly Improves Sjögren's Disease Activity in a Phase 2 Study
最新數據顯示,尼泊卡利單抗在2期研究中顯著改善乾燥綜合徵活動。
Late-Breaking Results Show Nipocalimab Significantly Improves Sjögren's Disease Activity in a Phase 2 Study
最新數據顯示,尼泊卡利單抗在2期研究中顯著改善乾燥綜合徵活動。
譯文內容由第三人軟體翻譯。